Stem Cells & Perinatal Therapies
Cell and perinatal products: promise, evidence, quality and clinical limitations.
Browse by collection
Explore interactive learning ↗Interactive cases & learning
A selection of published cases and interactive modules is shown below. Open the section title to browse the full directory.
-
Monkey Dance World Tour
-
Vasculitis VIII · CNS vasculitis, neuropathy, secondary vasculitis and VEXAS · Clinical Rounds
-
Vasculitis X · Treatment safety and evidence · Clinical Rounds
-
Vasculitis IX · Rheumatic emergencies · Clinical Rounds
-
Vasculitis VII · Behçet disease and Cogan syndrome · Clinical Rounds
-
Vasculitis V · Polyarteritis nodosa, DADA2, and Kawasaki disease · Clinical Rounds
-
Vasculitis IV · Eosinophilic granulomatosis with polyangiitis and anti-GBM disease · Clinical Rounds
-
Vasculitis III · Granulomatosis with polyangiitis and microscopic polyangiitis · Clinical Rounds
-
Vasculitis II · Giant cell arteritis, polymyalgia rheumatica, and Takayasu arteritis · Clinical Rounds
-
Vasculitis I · Recognizing vasculitis and its mimics · Clinical Rounds
-
Small Fall, Big Deal — RheumaPlay
Rheumatology in Perspective
Library
Search by topic, condition or question
1454 materials
Clear filtersClinical Review · Autoinflammatory conditions
Pediatric autoinflammation: focused key points
Pediatric autoinflammatory disease is a separate, substantial clinical topic. This chapter provides the essentials needed for an adult-focused collection and for safe continuity of care.
Clinical Review · Autoinflammatory conditions
Adult life, reproductive planning and comorbidity
A durable treatment plan must work through employment, relationships, pregnancy planning, travel and aging.
Clinical Review · Autoinflammatory conditions
Treatment, monitoring and AA amyloidosis
Control symptoms and silent inflammation while limiting treatment toxicity. The monitoring plan should follow the disease, the organs at risk and the drug.
Clinical Review · Autoinflammatory conditions
Adult PFAPA, undifferentiated disease and diagnostic boundaries
Some adults have a convincing inflammatory syndrome without a settled molecular label. Preserve diagnostic uncertainty while making a safe plan.
Clinical Review · Autoinflammatory conditions
Schnitzler syndrome and its mimics
Chronic urticaria-like lesions with systemic inflammation and monoclonal gammopathy require a different assessment from uncomplicated chronic urticaria.
Clinical Review · Autoinflammatory conditions
VEXAS: inflammation meets hematology
Think of VEXAS when adult-onset systemic inflammation and otherwise unexplained hematologic abnormalities travel together.
Clinical Review · Autoinflammatory conditions
MAS and HLH: a change in urgency
A rapidly deteriorating patient needs parallel evaluation for infection, hyperinflammation and organ failure. A diagnostic score must not become a reason to wait.
Clinical Review · Autoinflammatory conditions
Still’s disease across adult life
Systemic juvenile idiopathic arthritis and adult-onset Still’s disease sit within a common disease framework, while age-specific care remains important.
Clinical Review · Autoinflammatory conditions
CAPS, TRAPS, MKD and genetic interpretation
Use the phenotype to choose and interpret testing. A negative routine panel does not rule out every inherited or mosaic autoinflammatory condition.
Clinical Review · Autoinflammatory conditions
Familial Mediterranean fever in adults
Adult care must address attacks, inflammation between attacks, colchicine exposure and the risk of AA amyloidosis.
Clinical Review · Autoinflammatory conditions
The adult with recurrent inflammation
Start with the inflammatory pattern, its consequences and the dangerous alternatives. A recurrent fever is a problem to explain, not a diagnosis.
Essay · Spondyloarthritis (SpA)
ACR Convergence 2026: What Changes in Practice
A clinical review of ACR 2026: OA and axSpA guidance, MRI, retatrutide, PsA trials, dermatomyositis and lupus approvals, CAR-T safety, PMR, Sjögren disease and cardiovascular evidence.